Rocket One Inc. Increase (Decrease) in Other Accrued Liabilities
Rocket One Inc. (RKTO) reported Increase (Decrease) in Other Accrued Liabilities of $30.48 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2020-08-13
- Rocket One Inc. increase (decrease) in other accrued liabilities for the quarter ending 2019-06-30 was $9.79K.
- Rocket One Inc. increase (decrease) in other accrued liabilities for the quarter ending 2019-03-31 was $17.33K.
- Rocket One Inc. increase (decrease) in other accrued liabilities for fiscal 2019 was $30.48K, a 85.25% decline from fiscal 2018.
- Rocket One Inc. increase (decrease) in other accrued liabilities for fiscal 2018 was $206.67K.
| Period end | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 6 month | Increase (Decrease) in Other Accrued Liabilities 12 month |
|---|---|---|---|
| 2019-12-31 | $30.48K 10-K · filed 2020-03-02 | ||
| 2019-06-30 | $9.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $27.13K 10-Q · filed 2020-08-13 | |
| 2019-03-31 | $17.33K 10-Q · filed 2020-05-13 | ||
| 2018-12-31 | $206.67K 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |